C57BL/6NTac-Pdgfrbtm1(EGFP/Cre/ERT2)Wtsi/Ics

Status

Available to order

EMMA IDEM:12306
International strain nameC57BL/6NTac-Pdgfrbtm1(EGFP/Cre/ERT2)Wtsi/Ics
Alternative nameCEPD0063_5_A02
Strain typeTargeted Mutant Strains : Knock-in
Allele/Transgene symbolPdgfrbtm1(EGFP/Cre/ERT2)Wtsi
Gene/Transgene symbolPdgfrb

Information from provider

Provider ICS, Institut Clinique de la Souris
Provider affiliationICS, Institut Clinique de la Souris
Genetic informationThis mouse line originates from EUCOMM ES clone CEPD0063_5_A02. For further details on the construction of this clone see the page at the IMPC portal.
Quality Control/Disclaimer: The structure of the targeted mutation is not fully verified. It is recommended that the recipient confirms the mutation structure by Southern blotting. The Cre expression pattern is expected to mirror that of the host gene, but this may not be fully described and/or may be modified in the targeted allele. Although characterisation of the Cre expression pattern is an objective of EUCOMMTools this is an ongoing process which may be incomplete. It is therefore recommended that the recipient verifies the Cre expression pattern. For the tm1(EGFP/Cre/ERT2) type allele, if the promoter-driven selection cassette is flanked with Rox sites, it may be removed using Dre recombinase. Please be aware that the strain description may be subject to change. For the most recent description please consult the information pages for the appropriate product details at the IMPC portal.
Phenotypic informationPotential phenotyping data in the IMPC portal
ReferencesNone available

Information from EMMA

Archiving centreICS, Institut Clinique de la Souris, Illkirch-Graffenstaden, France

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • enlarged heart / IMPC
  • decreased circulating fructosamine level / IMPC
  • increased circulating triglyceride level / IMPC
  • abnormal seminal vesicle morphology / IMPC
  • preweaning lethality, complete penetrance / IMPC
MGI phenotypes (gene matching)
  • abnormal angiogenesis / MGI
  • abnormal heart morphology / MGI
  • overriding aortic valve / MGI
  • enlarged heart / MGI
  • double outlet right ventricle / MGI
  • schistocytosis / MGI
  • short snout / MGI
  • abnormal pulmonary artery morphology / MGI
  • abnormal kidney blood vessel morphology / MGI
  • kidney hemorrhage / MGI
  • decreased body size / MGI
  • anemia / MGI
  • abnormal blood vessel morphology / MGI
  • thymus hypoplasia / MGI
  • hemorrhage / MGI
  • intracranial hemorrhage / MGI
  • perinatal lethality / MGI
  • abnormal eye morphology / MGI
  • abnormal kidney physiology / MGI
  • no abnormal phenotype detected / MGI
  • disorganized myocardium / MGI
  • hydrops fetalis / MGI
  • abnormal erythrocyte morphology / MGI
  • micrognathia / MGI
  • anisocytosis / MGI
  • poikilocytosis / MGI
  • dilated heart right ventricle / MGI
  • abnormal retinal vasculature morphology / MGI
  • increased vascular permeability / MGI
  • retinal detachment / MGI
  • dilated heart atrium / MGI
  • cardiac fibrosis / MGI
  • thrombocytopenia / MGI
  • abnormal placenta vasculature / MGI
  • abnormal embryonic hematopoiesis / MGI
  • kidney cysts / MGI
  • pallor / MGI
  • abnormal pericyte morphology / MGI
  • abnormal retinal layer morphology / MGI
  • abnormal heart left ventricle morphology / MGI
  • abnormal venule morphology / MGI
  • right aortic arch / MGI
  • abnormal basement membrane morphology / MGI
  • abnormal trophoblast layer morphology / MGI
  • polychromatophilia / MGI
  • increased susceptibility to injury / MGI
  • glomerulosclerosis / MGI
  • abnormal renal glomerulus morphology / MGI
  • abnormal mesangial cell morphology / MGI
  • renal/urinary system phenotype / MGI
  • homeostasis/metabolism phenotype / MGI
  • cardiovascular system phenotype / MGI
  • vision/eye phenotype / MGI
  • decreased angiogenesis / MGI
  • abnormal vascular endothelial cell morphology / MGI
  • increased vascular endothelial cell number / MGI
  • retinal hemorrhage / MGI
  • eye hemorrhage / MGI
  • clinodactyly / MGI
  • decreased retinal ganglion cell number / MGI
  • retinal ganglion cell degeneration / MGI
  • absent podocytes / MGI
  • increased heart ventricle size / MGI
  • abnormal placental labyrinth vasculature morphology / MGI
  • petechiae / MGI
  • increased nucleated erythrocyte cell number / MGI
  • eye opacity / MGI
  • abnormal retinal blood vessel morphology / MGI
  • abnormal retinal blood vessel pattern / MGI
  • ventricular septal defect / MGI
  • atrioventricular septal defect / MGI
  • perimembraneous ventricular septal defect / MGI
  • muscular ventricular septal defect / MGI
  • kidney microaneurysm / MGI
  • vascular ring / MGI
  • abnormal left subclavian artery morphology / MGI
  • postnatal lethality, incomplete penetrance / MGI
  • perinatal lethality, incomplete penetrance / MGI
  • lethality throughout fetal growth and development, incomplete penetrance / MGI
  • decreased glomerular capillary number / MGI
  • absent mesangial cell / MGI
  • glomerulus hemorrhage / MGI
  • decreased kidney cell proliferation / MGI
  • glomerular capillary thrombosis / MGI
  • skin hemorrhage / MGI
  • purpura / MGI
  • decreased fibroblast proliferation / MGI
  • abnormal fibroblast migration / MGI
  • decreased fibroblast apoptosis / MGI
  • abnormal blood-retinal barrier function / MGI
  • increased retinal apoptosis / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).